相关实验视频
Updated: Jan 12, 2026

10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
15.2K
儿童药物研发奖励和基于医学成像的市场定价优化
Xiaoyan Mu1, Lin Wu2
1College of Continuing Education, China Pharmaceutical University, Nanjing, 210000, Jiangsu, China.
Scientific reports
|November 6, 2025
概括
这项研究引入了一种新的数据驱动方法,使用医学成像来改善儿科药物开发. 它优化了药品定价和研发效率,提高了儿童的可访问性.
科学领域:
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
- 人工智能在医学中的应用
背景情况:
- 儿童药物开发面临的挑战是由于儿童和成年人之间的生理差异.
- 现有的儿童药物疗效评估和安全监测方法不足.
- 需要提高儿科药物的研发效率和可访问性.
研究的目的:
- 建议使用医学成像数据为儿科药物开发提供数据驱动的激励机制.
- 优化儿科药物的市场定价,以提高研发效率和可访问性.
- 开发一种可靠的模型来评估儿科患者药物疗效和安全性.
主要方法:
- 收集了针对常见儿科疾病的多来源医学成像数据 (CT,MRI,X射线).
- 利用卷积神经网络 (CNN) 进行特征提取和U-Net进行图像细分,以评估有效性和安全性.
- 运用游戏理论用于研发激励机制设计和蒙特卡洛模拟用于动态定价优化.
主要成果:
- 显示显著的平均瘤体积减少32.7% (95%CI:28.4%-36.9%).
- 证实对器官体积的最小影响 (在±2厘米3以内).
- 通过动态定价策略确定了最佳的市场价格点.
结论:
- 拟议的数据驱动激励机制有效地促进了儿科药物开发.
- 医疗成像分析,再加上人工智能和游戏理论,提高了药物的疗效和安全性评估.
- 动态定价策略平衡了经济效益与儿科药物的社会可用性.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Products: Biologics, Biosimilars and Interchangeables
223
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
223
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Dosage Regimen: Individualization
160
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
160

